ANA.AQSE

Ananda Developments Plc
Ananda Developments - Result of AGM
9th August 2024, 09:56
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9295Z
Ananda Developments PLC
09 August 2024
 

ANANDA DEVELOPMENTS PLC

("Ananda" or the "Company")

 

Result of Annual General Meeting

 

Ananda Developments plc (AQSE: ANA) is pleased to announce that at the Annual General Meeting of the Company held earlier today all resolutions were duly passed by shareholders.

 

Proxy votes received ahead of the meeting were as follows:

Resolution Number

Resolution Name

% of Votes For

% of Votes Against

Total Votes Cast (Excluding Withheld)

Number of Votes  Withheld

 

 

 

 

 

 

01

To receive and adopt the Annual Report and Financial Statements for the year ended 31 January 2024

99.997%

0.003%

1,193,032,093

7,188

02

To re-elect Charles Morgan as a director of the Company

99.997%

0.003%

1,193,017,758

21,523

03

To re-elect Jeremy Sturgess-Smith as a director of the Company

99.997%

0.003%

1,193,017,758

21,523

04

To re-elect Stuart Piccaver as a director of the Company

99.997%

0.003%

1,193,017,758

21,523

05

To re-elect Clive Page as a director of the Company

99.997%

0.003%

1,193,017,758

21,523

06

To re-elect Melissa Sturgess  as a director of the Company

99.997%

0.003%

1,193,032,203

7,078

07

To re-elect John Treacy as a director of the Company

99.997%

0.003%

1,193,017,758

21,523

08

To re-appoint PKF Littlejohn as auditors to the Company

99.997%

0.003%

1,193,032,203

7,078

09

To approve authority to allot of Securities of the Company

99.996%

0.004%

1,193,032,203

7,078

10

To disapply Pre-emption Rights

99.812%

0.188%

1,193,032,203

7,078

 

To stay up to date with the latest developments at Ananda, we encourage you to follow and join our social media channels which are:  

  

·      Register at our Investor Hub: https://investors.anandadevelopments.com/s/a66906

·      Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=   

·      LinkedIn: https://www.linkedin.com/company/anadevelopments/   

·      Twitter: https://twitter.com/AnandaPlc

·      Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor

 

-Ends-

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For more information please contact:

InvestorHub

Engage with us directly at Ananda Developments Investor Hub

 

Sign up at https://investors.anandadevelopments.com/s/a66906

 

ANANDA DEVELOPMENTS PLC

Chief Executive Officer

Melissa Sturgess


Finance Director

Jeremy Sturgess-Smith

 

+44 (0)7463 686 497 ir@anandadevelopments.com

SP ANGEL CORPORATE FINANCE LLP

Corporate Finance

Richard Morrison

Caroline Rowe

+44 (0)20 3470 0470

Corporate Broking

Abigail Wayne

Rob Rees

 


Yellow Jersey PR

Charles Goodwin

Soraya Jackson

+44 (0)20 3004 9512

 

 

About Ananda Developments

Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions

For further information on the Company visit https://anandadevelopments.com/ or sign up at https://investors.anandadevelopments.com/s/a66906.

 

https://investors.anandadevelopments.com/link/YeN3br

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXEANPNESSLEEA]]>
TwitterFacebookLinkedIn